PTPase inhibitors (IDD/Kaken)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePTPase inhibitors (IDD/Kaken)
Drug Alias NameIDD-3 (Institute for Diabetes Discovery)PTP1B inhibitors (Alinea/Kaken)PTPase inhibitors (Institute of Diabetes Discovery/Kaken)PTP1B inhibitors (IDD/Kaken)PTPase inhibitors (Alinea/Kaken) +[7] 
ClassificationSmall molecules
Mechanisms of ActionProtein-tyrosine phosphatase 1B inhibitorsInsulin sensitizers
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Institute For Diabetes Discovery Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Institute For Diabetes Discovery LlcAlinea Pharmaceuticals IncKaken Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A